arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

agilon health, inc.

AGL
$95.85 ▲ +9.27 (+10.71%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
7 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

agilon health, inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.6B
Dividend Yield
Revenue Growth -2.1%
Op. Margin -7.8%
ROIC -1328.1%
FCF / Share $-7.19
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.93B
↓ -2.1%
Net Income Profit after all expenses
$-391.35M
↓ -50.4%
Operating Margin Operating profit as % of sales
-7.8%
↓ -62.0% 17th
FCF / Share Free cash flow per share
$-7.19
↓ -66.3%
Long-Term Debt Long-term obligations
$34.99M
— +0.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
19
Financial Health
14
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters